Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 26, 2002
Do levels of immunoglobulin G antibodies to foods predict the development of immunoglobulin E antibodies to cat, dog and/or mite?
P E D Eysink, P J E Bindels, S O Stapel, et al.
Allergy
|
March 1, 1995
Grass pollen immunotherapy induces highly cross-reactive IgG antibodies to group V allergen from different grass species
R van Ree, P Z Brewczyński, K Y Tan, et al.
Annals of the Rheumatic Diseases
|
July 15, 2009
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis
R M Thurlings, O Teng, K Vos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 7, 1999
Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study
P E Eysink, M H De Jong, P J Bindels, et al.
Clinical and Experimental Rheumatology
|
September 1, 1996
Juvenile chronic arthritis and coeliac disease in The Netherlands
E K George, R Hertzberger-ten Cate, L W van Suijlekom-Smit, et al.
Annals of the Rheumatic Diseases
|
December 21, 2006
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation
M K de Vries, G J Wolbink, S O Stapel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma
T C van der Pouw Kraan, L C Boeije, E R de Groot, et al.
Annals of the Rheumatic Diseases
|
July 17, 2009
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
B J F van den Bemt, K Vos, A A den Broeder, et al.
Annals of the Rheumatic Diseases
|
April 1, 2008
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
M K de Vries, I E van der Horst-Bruinsma, M T Nurmohamed, et al.
Genes and Immunity
|
February 24, 2001
An IL-13 promoter polymorphism associated with increased risk of allergic asthma
T C van der Pouw Kraan, A van Veen, L C Boeije, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 26, 2002
Do levels of immunoglobulin G antibodies to foods predict the development of immunoglobulin E antibodies to cat, dog and/or mite?
P E D Eysink, P J E Bindels, S O Stapel, et al.
Allergy
|
March 1, 1995
Grass pollen immunotherapy induces highly cross-reactive IgG antibodies to group V allergen from different grass species
R van Ree, P Z Brewczyński, K Y Tan, et al.
Annals of the Rheumatic Diseases
|
July 15, 2009
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis
R M Thurlings, O Teng, K Vos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 7, 1999
Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study
P E Eysink, M H De Jong, P J Bindels, et al.
Clinical and Experimental Rheumatology
|
September 1, 1996
Juvenile chronic arthritis and coeliac disease in The Netherlands
E K George, R Hertzberger-ten Cate, L W van Suijlekom-Smit, et al.
Annals of the Rheumatic Diseases
|
December 21, 2006
Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation
M K de Vries, G J Wolbink, S O Stapel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma
T C van der Pouw Kraan, L C Boeije, E R de Groot, et al.
Annals of the Rheumatic Diseases
|
July 17, 2009
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
B J F van den Bemt, K Vos, A A den Broeder, et al.
Annals of the Rheumatic Diseases
|
April 1, 2008
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
M K de Vries, I E van der Horst-Bruinsma, M T Nurmohamed, et al.
Genes and Immunity
|
February 24, 2001
An IL-13 promoter polymorphism associated with increased risk of allergic asthma
T C van der Pouw Kraan, A van Veen, L C Boeije, et al.
Page
of 5